» Authors » Michal Marzec

Michal Marzec

Explore the profile of Michal Marzec including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 26
Citations 1280
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pierchala A, Rozanski K, Dulinski M, Gorczyca Z, Marzec M, Czub R
Isotopes Environ Health Stud . 2019 May; 55(3):290-307. PMID: 31037964
A thorough evaluation of measurement uncertainty together with control of short-term and long-term precision of measurements should be a basis of any successful quality assurance/quality control (QA/QC) strategy aimed at...
2.
Watek M, Durnas B, Wollny T, Pasiarski M, Gozdz S, Marzec M, et al.
Lipids Health Dis . 2017 Dec; 16(1):235. PMID: 29216917
Background: Impaired apoptotic pathways in leukemic cells enable them to grow in an uncontrolled way. Moreover, aberrations in the apoptotic pathways are the main factor of leukemic cells drug resistance....
3.
Marzec M, Hawkes C, Eletto D, Boyle S, Rosenfeld R, Hwa V, et al.
Endocrinology . 2016 Mar; 157(5):1914-28. PMID: 26982636
IGFs are critical for normal intrauterine and childhood growth and sustaining health throughout life. We showed previously that the production of IGF-1 and IGF-2 requires interaction with the chaperone glucose-regulated...
4.
Durnas B, Watek M, Wollny T, Niemirowicz K, Marzec M, Bucki R, et al.
Onco Targets Ther . 2016 Feb; 9:469-75. PMID: 26858528
Diagnosis of infections in cancer patients is usually problematic since differentiating between infection and fever of unknown origin is often a considerable clinical challenge. In general, increase concentration of blood...
5.
Marzec M, Halasa K, Liu X, Wang H, Cheng M, Baldwin D, et al.
J Immunol . 2013 Nov; 191(12):6200-7. PMID: 24218456
Anaplastic lymphoma kinase (ALK), physiologically expressed only by nervous system cells, displays a remarkable capacity to transform CD4(+) T lymphocytes and other types of nonneural cells. In this study, we...
6.
Lee S, Arias-Mendoza F, Poptani H, James Delikatny E, Wasik M, Marzec M, et al.
PET Clin . 2012 Jun; 7(1):119-26. PMID: 22737093
No abstract available.
7.
Lee S, Marzec M, Liu X, Wehrli S, Kantekure K, Ragunath P, et al.
NMR Biomed . 2012 Jun; 26(1):106-14. PMID: 22711601
The application of kinase inhibitors in cancer treatment is growing rapidly. However, methods for monitoring the effectiveness of the inhibitors are still poorly developed and currently rely mainly on the...
8.
Marzec M, Eletto D, Argon Y
Biochim Biophys Acta . 2011 Nov; 1823(3):774-87. PMID: 22079671
Glucose-regulated protein 94 is the HSP90-like protein in the lumen of the endoplasmic reticulum and therefore it chaperones secreted and membrane proteins. It has essential functions in development and physiology...
9.
Marzec M, Liu X, Wysocka M, Rook A, Odum N, Wasik M
PLoS One . 2011 Sep; 6(9):e24849. PMID: 21949767
Background: mTOR kinase forms the mTORC1 complex by associating with raptor and other proteins and affects a number of key cell functions. mTORC1 activates p70S6kinase 1 (p70S6K1) and inhibits 4E-binding...
10.
Szydlo K, Orszulak W, Trusz-Gluza M, Tabor Z, Wita K, Orszulak M, et al.
J Electrocardiol . 2011 Mar; 44(2):142-7. PMID: 21353062
Unlabelled: In the study, there has been retrospectively analyzed heart rate turbulence in postinfarction patients. The cohort of 158 patients consisted of 94 patients with documented ventricular tachycardia and/or ventricular...